![H. Shepard](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
H. Shepard
Founder at Enosi Life Sciences Corp.
H. Shepard active positions
Companies | Position | Start | End |
---|---|---|---|
Enosi Life Sciences Corp.
![]() Enosi Life Sciences Corp. BiotechnologyHealth Technology Enosi Life Sciences Corp. is a drug research and development company that focuses on providing therapeutics for autoimmune diseases and cancer. The private company is based in San Diego, CA, and was founded in 2018 by H. Michael Shepard and Marc Feldmann. Enosi Life Sciences combines their expertise with Dr. James N. Woody's medical, scientific, and management expertise to expand therapeutic options. The company was founded by Professor Sir Marc Feldmann and Dr. H. Michael Shepard, who are world-renowned scientists in the field of cancer and autoimmune diseases. Patrick W. Gray has been the CEO of the company since 2021. | Director/Board Member | 2018-08-15 | - |
Chief Tech/Sci/R&D Officer | 2018-08-15 | - | |
Founder | 2018-08-15 | - | |
President | 2018-08-15 | - | |
Chief Executive Officer | 2018-08-15 | 2021-11-08 |
Career history of H. Shepard
Former positions of H. Shepard
Companies | Position | Start | End |
---|---|---|---|
HALOZYME THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2009-06-14 | 2017-01-31 |
Receptor BioLogix, Inc.
![]() Receptor BioLogix, Inc. BiotechnologyHealth Technology Receptor BioLogix, Inc. provides receptor based biological therapeutics. It develops an intron fusion protein platform for the discovery of novel alternative forms splice variants of human proteins with therapeutic potential. The company was founded by H. Michael Shepard, John P. Adelman and Gail M. Clinton on May 27, 2003 and is headquartered in Mountain View, CA. | Chief Tech/Sci/R&D Officer | 2003-05-26 | 2008-01-01 |
Founder | 2003-05-26 | 2008-01-01 | |
President | 2003-05-26 | 2008-01-01 | |
NewBiotics, Inc.
![]() NewBiotics, Inc. Pharmaceuticals: MajorHealth Technology NewBiotics, Inc. develops pharmaceutical drugs to treat cancer and infectious disease. It applies its Enzyme Catalyzed Therapeutic Activation technology to develop pharmaceuticals that transform drug resistance into therapeutic advantage. The company was founded by H. Michael Shepard and Geoffrey Myles Wahl in 1997 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 1996-12-31 | 2007-12-31 |
President | 1996-12-31 | 2007-12-31 | |
Canji, Inc.
![]() Canji, Inc. Medical/Nursing ServicesHealth Services Part of Merck & Co., Inc., Canji, Inc. is a gene therapy research company. The company is based in San Diego, CA. Canji was acquired by Schering-Plough Corp., part of Merck & Co., Inc. from November 03, 2009 on February 02, 1996 for $54.50 million. | Chief Tech/Sci/R&D Officer | 1991-12-31 | - |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 1979-12-31 | - |
NEVIS BRANDS INC. | Director/Board Member | 2020-07-08 | - |
Independent Dir/Board Member | 2020-07-08 | - |
Training of H. Shepard
Indiana University | Doctorate Degree |
University of California, Davis | Undergraduate Degree |
Statistics
International
United States | 9 |
Canada | 2 |
Operational
Chief Tech/Sci/R&D Officer | 5 |
President | 3 |
Founder | 2 |
Sectoral
Health Technology | 7 |
Consumer Services | 3 |
Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
HALOZYME THERAPEUTICS, INC. | Health Technology |
NEVIS BRANDS INC. | Health Technology |
Private companies | 5 |
---|---|
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
NewBiotics, Inc.
![]() NewBiotics, Inc. Pharmaceuticals: MajorHealth Technology NewBiotics, Inc. develops pharmaceutical drugs to treat cancer and infectious disease. It applies its Enzyme Catalyzed Therapeutic Activation technology to develop pharmaceuticals that transform drug resistance into therapeutic advantage. The company was founded by H. Michael Shepard and Geoffrey Myles Wahl in 1997 and is headquartered in San Diego, CA. | Health Technology |
Receptor BioLogix, Inc.
![]() Receptor BioLogix, Inc. BiotechnologyHealth Technology Receptor BioLogix, Inc. provides receptor based biological therapeutics. It develops an intron fusion protein platform for the discovery of novel alternative forms splice variants of human proteins with therapeutic potential. The company was founded by H. Michael Shepard, John P. Adelman and Gail M. Clinton on May 27, 2003 and is headquartered in Mountain View, CA. | Health Technology |
Canji, Inc.
![]() Canji, Inc. Medical/Nursing ServicesHealth Services Part of Merck & Co., Inc., Canji, Inc. is a gene therapy research company. The company is based in San Diego, CA. Canji was acquired by Schering-Plough Corp., part of Merck & Co., Inc. from November 03, 2009 on February 02, 1996 for $54.50 million. | Health Services |
Enosi Life Sciences Corp.
![]() Enosi Life Sciences Corp. BiotechnologyHealth Technology Enosi Life Sciences Corp. is a drug research and development company that focuses on providing therapeutics for autoimmune diseases and cancer. The private company is based in San Diego, CA, and was founded in 2018 by H. Michael Shepard and Marc Feldmann. Enosi Life Sciences combines their expertise with Dr. James N. Woody's medical, scientific, and management expertise to expand therapeutic options. The company was founded by Professor Sir Marc Feldmann and Dr. H. Michael Shepard, who are world-renowned scientists in the field of cancer and autoimmune diseases. Patrick W. Gray has been the CEO of the company since 2021. | Health Technology |
- Stock Market
- Insiders
- H. Shepard
- Experience